Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 0.27% vs -1.08% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 126.86% vs -42.39% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 4.19% vs 4.90% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 12.78% vs 16.13% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Towa Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 0.27% vs -1.08% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 7.38% vs 15.12% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 126.86% vs -42.39% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 437.83% vs -51.88% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 4.19% vs 4.90% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 12.24% vs 32.92% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 12.78% vs 16.13% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 36.85% vs 102.27% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






